Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2309178

NC(c1ccccc1)C1CC1.[Cl-].[H+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.50
DPP4 P27487 2/20 0.44
F2 P00734 1/20 0.44
AKT2 P31751 1/20 0.42
OPRM1 P35372 4/20 0.40
OPRD1 P41143 4/20 0.40
OPRK1 P41145 4/20 0.40
OPRL1 P41146 4/20 0.40
CYP3A4 P08684 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1423740 0.95 IDO1 (0.54) IDO1DPP4F2AKT2OPRM1
SCHEMBL5945366 0.95 IDO1 (0.54) IDO1DPP4F2AKT2OPRM1
SCHEMBL2149539 0.95 IDO1 (0.54) IDO1DPP4F2AKT2OPRM1
Hydrochloric Acid SCHEMBL18336573 0.93 IDO1 (0.55) IDO1DPP4F2AKT2OPRM1
Hydrochloric Acid SCHEMBL2309180 0.93 IDO1 (0.55) IDO1DPP4F2AKT2OPRM1
Hydrochloric Acid SCHEMBL3323789 0.93 IDO1 (0.55) IDO1DPP4F2AKT2OPRM1
SCHEMBL8572567 0.87 IDO1 (0.47) IDO1DPP4F2AKT2OPRM1
SCHEMBL2677106 0.86 IDO1 (0.50) IDO1DPP4F2AKT2OPRM1
SCHEMBL11885874 0.86 IDO1 (0.50) IDO1DPP4F2AKT2OPRM1
SCHEMBL20721292 0.86 IDO1 (0.55) IDO1DPP4F2AKT2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044069-B2 Compounds as calcium channel blockers ABBOTT LABORATORIES (US) 2011-10-25 US disclosed
EP-2350002-A1 NOVEL COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Abbott Laboratories (US) 2011-08-03 EP disclosed
US-20100093730-A1 NOVEL COMPOUNDS AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2010-04-15 US disclosed
WO-2010039947-A1 NOVEL COMPOUNDS AS CALCIUM CHANNEL BLOCKERS ABBOTT LABORATORIES (US) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093730-A1 NOVEL COMPOUNDS AS CALCIUM CHANNEL BLOCKERS CACNA1E, CACNA1S, CACNA1D IDO1 2989/4885DPP4 4214/4885F2 2840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.